Ameritas Investment Partners’s CytRx Corp CYTR Stock Holding History

Ameritas Investment Partners’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-833	Closed	-$2K	–	3153
2017 Q1	$2K	Buy	+833	New	+$2.11K	﹤0.01%	2935

Other funds holding CYTR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

ECM

Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return

Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Ameritas Investment Partners's CYTR Position: Q2 2017 in Review

Ameritas Investment Partners sold out of CytRx Corp (CYTR) in Q2 2017, closing a stake of 833 shares — an estimated $2K sold.

Ameritas Investment Partners first reported a position in CYTR in Q1 2017 and held it in 1 quarter. The position peaked at $2K in Q1 2017. 54 funds tracked by Wall St. Rank hold CYTR as of Q2 2017.

Ameritas Investment Partners reported no remaining CytRx Corp position as of Q2 2017 after selling out during the quarter.
Ameritas Investment Partners sold 833 CytRx Corp shares in Q2 2017, an estimated $2K.
Ameritas Investment Partners first reported a position in CytRx Corp in Q1 2017 and held it in 1 quarter.
Ameritas Investment Partners's CytRx Corp position peaked at $2K in Q1 2017.
54 funds tracked by Wall St. Rank held CytRx Corp as of Q2 2017.

Based on Ameritas Investment Partners's 13F filing for Q2 2017, filed 15 Aug 2017.